Revolution Medicines RVMD
NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Other Non-Current Assets (2019 - 2026)

Updated

Revolution Medicines (RVMD) posted Other Non-Current Assets of $42.45 million for Q2 2026, up 35.1% from $31.42 million a year earlier and up 22.3% from the prior quarter.

Analysis

Revolution Medicines (RVMD) Other Non-Current Assets (2019 - 2026) Analysis & Trends

At the end of FY2025, Revolution Medicines' Other Non-Current Assets came in at $24.15 million, up 99.1% from FY2024.

  • Annual Other Non-Current Assets has increased for five consecutive years, with a five-year compound annual growth rate of 86.0% (FY2020 to FY2025).
  • In prior years, Revolution Medicines' Other Non-Current Assets was $12.13 million in FY2024 (+72.5%), $7.03 million in FY2023 (+146.1%), $2.86 million in FY2022 (+64.5%) and $1.74 million in FY2021 (+60.2%).
  • The Q2 2026 figure stands as the highest quarterly Other Non-Current Assets in data going back to Q1 2019.
  • On a year-over-year basis, Other Non-Current Assets has increased in each of the last seven quarters, with growth averaging 115.1% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q3 2023, with growth of 553.5%; the weakest was Q3 2024, with a decline of 9.5%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $34.71 million (Q1 2026), $24.15 million (Q4 2025) and $16.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 14.27 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 10.73 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 4.75 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 9.94 Bn
10 Revolution Medicines 37.70 Bn 27.90 Bn - 62.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 62.07 Mn
Mar 31, 2026 54.05 Mn
Dec 31, 2025 43.79 Mn
Sep 30, 2025 36.58 Mn
Jun 30, 2025 35.34 Mn
Mar 31, 2025 16.83 Mn
Dec 31, 2024 17.57 Mn
Sep 30, 2024 13.16 Mn
Jun 30, 2024 11.31 Mn
Mar 31, 2024 7.19 Mn
Dec 31, 2023 10.06 Mn
Sep 30, 2023 13.74 Mn
Jun 30, 2023 5.29 Mn
Mar 31, 2023 4.51 Mn
Dec 31, 2022 6.33 Mn
Sep 30, 2022 4.33 Mn
Jun 30, 2022 4.20 Mn
Mar 31, 2022 4.33 Mn
Dec 31, 2021 1.74 Mn
Sep 30, 2021 1.08 Mn
API Access

Revolution Medicines Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RVMD&period=max&api_key=YOUR_API_KEY